Gene therapy’s biggest bottleneck is delivery. Tomorrow at the Freedom Summit in New Hampshire, our CEO and cofounder @ekelsic addresses how AI-designed AAV capsids are solving this problem, and unlocking genetic agency – an individual’s ability to take action at the genetic
Dyno Therapeutics is a pioneer in applying artificial intelligence to gene therapy, focused on AAV capsid engineering. Join our startup: dynotx.com

